Likewise, in laboratory testing issued for screening patients with ILDs, including IPF, the Krebs von den Lungen 6 (KL-6) biomarker is referred, which is not widely used[29, 30]. The gene discussed is MUC1; the disease is idiopathic pulmonary fibrosis.